Evonik Evonik

X

Find Ethanolamine Oleate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Ethanolamine Oleate
Also known as: Ethamolin, Monoethanolamine oleate, Oldamin, 2272-11-9, Beta-hydroxyethylammonium oleate, Oleic acid (ethanolamine)
Molecular Formula
C20H41NO3
Molecular Weight
343.5  g/mol
InChI Key
KGWDUNBJIMUFAP-KVVVOXFISA-N
FDA UNII
U4RY8MRX7C

Ethanolamine Oleate is a synthetic preparation of oleic acid and ethanolamine, a first generation monoethanolamine with sclerotherapeutic activity. Ethanolamine oleate causes an acute, dose-related inflammatory reaction of the intimal endothelium of the vein. This leads to scarring at the inner wall of the veins and possible occlusion of the veins. The oleic acid component may also transiently activate coagulation and fibrinolytic systems through the release of tissue factor and activation of Hageman factor.
1 2D Structure

Ethanolamine Oleate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-aminoethanol;(Z)-octadec-9-enoic acid
2.1.2 InChI
InChI=1S/C18H34O2.C2H7NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;3-1-2-4/h9-10H,2-8,11-17H2,1H3,(H,19,20);4H,1-3H2/b10-9-;
2.1.3 InChI Key
KGWDUNBJIMUFAP-KVVVOXFISA-N
2.1.4 Canonical SMILES
CCCCCCCCC=CCCCCCCCC(=O)O.C(CO)N
2.1.5 Isomeric SMILES
CCCCCCCC/C=C\CCCCCCCC(=O)O.C(CO)N
2.2 Other Identifiers
2.2.1 UNII
U4RY8MRX7C
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ethamolin

2. Oleic Acid, 2-aminoethyl Ester

3. Monoethanolamine Oleate

2.3.2 Depositor-Supplied Synonyms

1. Ethamolin

2. Monoethanolamine Oleate

3. Oldamin

4. 2272-11-9

5. Beta-hydroxyethylammonium Oleate

6. Oleic Acid (ethanolamine)

7. U4ry8mrx7c

8. 2-aminoethan-1-ol Oleate

9. Ethanolamine Oleate [usan]

10. Monoethanolamine Oleate [inn]

11. Nsc-760382

12. 2-aminoethanol;(z)-octadec-9-enoic Acid

13. Ethanolamine Oleate (usan)

14. Oleic Acid Compound With 2-aminoethanol (1:1)

15. Monoethanolamine Oleate (jan)

16. Neosclerol

17. Monolate

18. Moramin

19. Varicetin

20. Varex

21. 9-octadecenoic Acid (z)-, Compound With 2-aminoethanol (1:1)

22. Monoethanolamine Oleate [jan]

23. Ethamolin (tn)

24. Esclerosina

25. Antivariz

26. Phlebocid

27. Thanomin

28. Tindanol

29. Neo-varicane

30. Ethanolamine-oleate

31. Oldamin (tn)

32. Monoethanolamini Oleas

33. Monoaethanolamini Oleas

34. Monoetanolammina Oleato

35. Cis-9-octadecenoic Acid, Ethanolamine Salt

36. Unii-u4ry8mrx7c

37. Oleate De Monoethanolamine

38. Oleato De Monoetanolaminio

39. Oleic Acid Monoethanolamine

40. Oleic Acid Ethanolamine Salt

41. Oleic Acid, Ethanolamine Salt

42. Schembl146090

43. Ccris 3324

44. Monoetanolammina Oleato [dcit]

45. Oleic Acid Monoethanolamine Salt

46. Chembl3989529

47. Dtxsid8023008

48. Ethanolamine Oleate [mi]

49. Oleic Acid, 2-aminoethanol Salt

50. Oleic Acid, Monoethanolamine Salt

51. Chebi:178699

52. 9-octadecenoic Acid (z)-, Compd. With 2-aminoethanol (1:1)

53. Ethanolamine Oleate [vandf]

54. Hy-b2096

55. Monoethanolamini Oleas [inn-latin]

56. Einecs 218-878-0

57. Fo-611

58. Db06689

59. Monoethanolamine Oleate [mart.]

60. Nsc 760382

61. Monoethanolamine Oleate [who-dd]

62. Ethanolamine Oleate [orange Book]

63. Oleate De Monoethanolamine [inn-french]

64. Oleato De Monoetanolaminio [inn-spanish]

65. Cs-0017525

66. D02276

67. Ec 218-878-0

68. Oleic Acid, Compd. With 2-aminoethanol (1:1)

69. W-109765

70. (9z)-octadec-9-enoic Acid - 2-aminoethanol (1:1)

71. 9-octadecenoic Acid (9z)-, Compd. With 2-aminoethanol (1:1)

72. 9-octadecenoic Acid (z)-, Compd With 2-aminoethanol (1:1)

2.4 Create Date
2005-10-11
3 Chemical and Physical Properties
Molecular Weight 343.5 g/mol
Molecular Formula C20H41NO3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count16
Exact Mass343.30864417 g/mol
Monoisotopic Mass343.30864417 g/mol
Topological Polar Surface Area83.6 Ų
Heavy Atom Count24
Formal Charge0
Complexity244
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameEthamolin
PubMed HealthEthanolamine (Injection)
Drug ClassesSclerosing Agent
Drug LabelETHAMOLIN (Ethanolamine Oleate) Injection is a mild sclerosing agent. Chemically it is C17H33COOHNH2CH2CH2OH. It has the following structure:The empirical formula is C20H41NO3, representing a molecular weight of 343.55.ETHAMOLIN Injection consis...
Active IngredientEthanolamine oleate
Dosage FormInjectable
RouteInjection
Strength50mg/ml
Market StatusPrescription
CompanyQol Medcl

2 of 2  
Drug NameEthamolin
PubMed HealthEthanolamine (Injection)
Drug ClassesSclerosing Agent
Drug LabelETHAMOLIN (Ethanolamine Oleate) Injection is a mild sclerosing agent. Chemically it is C17H33COOHNH2CH2CH2OH. It has the following structure:The empirical formula is C20H41NO3, representing a molecular weight of 343.55.ETHAMOLIN Injection consis...
Active IngredientEthanolamine oleate
Dosage FormInjectable
RouteInjection
Strength50mg/ml
Market StatusPrescription
CompanyQol Medcl

4.2 Drug Indication

For the treatment of patients with esophageal varices that have recently bled, to prevent rebleeding.


5 Pharmacology and Biochemistry
5.1 Pharmacology

When injected intravenously, ethanolamine oleate acts primarily by irritation of the intimal endothelium of the vein and produces a sterile dose-related inflammatory response. This results in fibrosis and possible occlusion of the vein. Ethanolamine oleate also rapidly diffuses through the venous wall and produces a dose-related extravascular inflammatory reaction.


5.2 MeSH Pharmacological Classification

Sclerosing Solutions

Chemical agents injected into blood vessels and lymphatic sinuses to shrink or cause localized THROMBOSIS; FIBROSIS, and obliteration of the vessels. This treatment is applied in a number of conditions such as VARICOSE VEINS; HEMORRHOIDS; GASTRIC VARICES; ESOPHAGEAL VARICES; PEPTIC ULCER HEMORRHAGE. (See all compounds classified as Sclerosing Solutions.)


5.3 FDA Pharmacological Classification
5.3.1 Pharmacological Classes
Sclerosing Agent [EPC]; Vascular Sclerosing Activity [PE]; Sclerosing Activity [MoA]
5.4 ATC Code

C - Cardiovascular system

C05 - Vasoprotectives

C05B - Antivaricose therapy

C05BB - Sclerosing agents for local injection

C05BB01 - Monoethanolamine oleate


5.5 Absorption, Distribution and Excretion

Absorption

After injection into an esophageal varix, ethanolamine oleate is cleared from the injection site within five minutes via the portal vein. Some of the medication also flows into the azygos vein through the periesophageal vein if more than 20 mL is injected.


5.6 Mechanism of Action

The oleic acid component of ethanolamine oleate is responsible for the inflammatory response, and may also activate coagulation in vivo by release of tissue factor and activation of Hageman factor. The ethanolamine component, however, may inhibit fibrin clot formation by chelating calcium, so that a procoagulant action of ethanolamine oleate has not been demonstrated.


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY